Sanne de Bruin

233 List of publications Collaborator COVID-Biobank consortium Zhang Q, Bastard P, Liu Z, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science [Internet]. 2020;370(6515). Available from: http:// www.ncbi.nlm.nih.gov/pubmed/32972995 Asano T, Boisson B, Onodi F, et al. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19. Sci Immunol [Internet]. 2021;6(62). Available from: http://www.ncbi.nlm.nih.gov/pubmed/34413140 Bastard P, Rosen LB, Zhang Q, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science [Internet]. 2020;370(6515). Available from: http:// www.ncbi.nlm.nih.gov/pubmed/32972996 Bastard P, Gervais A, Le Voyer T, et al. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Sci Immunol [Internet]. 2021;6(62). Available from: http://www.ncbi.nlm.nih . gov/pubmed/34413139 Koning R, Bastard P, Casanova J-L, et al. Autoantibodies against type I interferons are associated with multi-organ failure in COVID-19 patients. Intensive Care Med [Internet]. 2021;47(6):704–6. Caniels TG, Bontjer I, van der Straten K, et al. Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination. Sci Adv [Internet]. 2021 Sep 3;7(36):eabj5365. van Zeggeren IE, Boelen A, et al. Sex steroid hormones are associated with mortality in COVID-19 patients: Level of sex hormones in severe COVID-19. Medicine (Baltimore) [Internet]. 2021 Aug 27;100(34):e27072. Appelman B, van der Straten K, Lavell AHA, et al. Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccination. EBioMedicine [In- ternet]. 2021 Sep 24;72:103589. Zonneveld R, Jurriaans S, van Gool T, et al. Head-to-head validation of six immunoassays for SARS-CoV-2 in hospitalized patients. J Clin Virol [Internet]. 2021;139:104821.